Background. Infectious diseases (IDs) cause widespread morbidity and mortality. We describe the epidemiology of ID hospitalizations in the United States with use of a nationally representative database.
charges attributed to ID hospitalizations among infants [14] and older adults [12] have been reported to be substantial and increasing over time. There are no recent studies that examine the burden and epidemiology of ID hospitalizations for patients of all ages in the United States. In the present study, we use a nationally representative database to describe the epidemiology and trends of ID hospitalizations in the United States for the 9-year period 1998-2006.
METHODS
We analyzed the occurrence and rate of primary ID hospitalizations in the United States (US) population. Hospital discharge data from the Nationwide Inpatient Sample for 1998-2006 were evaluated [16] . The Nationwide Inpatient Sample is a nationally representative survey of hospitalizations conducted by the Healthcare Cost and Utilization Project in collaboration with the participating states. It is the largest all-payer inpatient dataset in the United States and includes a 20% sample of US community hospitals that approximates 20% of all US community hospitals [17] . Participating hospitals are short-term, non-federal general and specialty hospitals sampled from up to 38 states. Robust estimates of the number of hospitalizations in the US were calculated using the Healthcare Cost and Utilization Project weighting methodology [17, 18] . SUDAAN software, version 10.0.0 (RTI International), was used to accommodate the complex sample survey design and to generate estimates of standard errors (SEs) [19] . If the relative SE of national estimates exceeded 0.30 or if the number of unweighted outpatient visits or hospitalizations in a strata was !30, the estimates were considered to be unreliable and were not presented [20] .
Hospitalizations with an International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM) [21] code for an ID listed as the primary diagnosis on the discharge record were studied. Overall ID and ID subgroups were defined using a classification scheme for ICD-9-CM codes described elsewhere [2, 22] . The following ID groups were used for subgroup-specific analysis (see Table 1 for corresponding codes): tuberculosis; meningitis; septicemia; HIV/AIDS; hepatobiliary disease; mycoses; infections of the heart; upper respiratory tract infections; lower respiratory tract infections (LRTIs); abdominal and rectal infections; kidney, urinary tract, and bladder infections; cellulitis; enteric infections; viral central nervous system infections; infection due to internal prosthetic device, implant, and graft; postoperative infection; osteomyelitis, periostitis, and other bone infection; inflammatory disease of female pelvic organs; and infections related to pregnancy, childbirth, or puerperium. Hospitalization rates and their associated 95% confidence intervals (CIs) were expressed as the weighted number of hospitalizations per population (10,000 persons for overall ID hospitalizations and 100,000 persons for disease subgroups). Denominators were determined by using the National Center for Health Statistics bridged race population estimates for the study period [23, 24] . Age-adjusted rates with 95% CIs were calculated using the direct method, with the 2000 projected US population as the standard [25] . The unit of analysis for the study was a hospitalization. Standard errors of hospitalization estimates were calculated using SUDAAN software to account for the sampling design of the Nationwide Inpatient Sample [19, 20, 26] and were used to calculate 95% CIs for hospitalization rates. T-tests were performed using SUDAAN to test for significant differences for duration of stay and hospital charges [27] . A weighted least squares technique was used to assess changes in hospitalization rates over the study period, accounting for the complex sample survey design of the Nationwide Inpatient Sample [28] .
Records for primary ID hospitalizations were examined by age group, sex, race/ethnicity of the patient, region of hospital location (standard census regions of Northeast, Midwest, South, and West), outcome (discharged or died during hospitalization), and admission month. Race/ethnicity was recorded as 1 variable (non-Hispanic white, non-Hispanic black, Hispanic, Asian/Pacific Islander, American Indian/Alaska Native, or other race) [18] . Hospitalizations for American Indian/Alaska Native persons were not examined because of the small number of hospitalizations and the fact that federal health care facilities (where most American Indian/Alaska Native persons access health care services) are not included in the Nationwide Inpatient Sample [29] .
Some hospitalization records had missing information regarding patient sex (0.22%; SE, 0.01%), race/ethnicity (25.8%; SE, 0.58%), duration of stay (0.13%; SE, 0.03%), and hospital charges (2.29%; SE, 0.21%); adjustments were not made for missing data. Accompanying diagnoses and procedures listed with ID on the hospitalization records were also examined overall, by sex, and by age group (age groups were 0-19 years, 20-49 years, and у50 years). Finally, hospital duration of stay and total hospital charges were assessed.
RESULTS
Hospitalization rates: overall rates and trends. Over the period 1998-2006, an estimated 40,085,978 (SE, 255,418) hospitalizations with a first-listed infectious disease occurred in the United States, an average annual age-adjusted hospitalization rate of 154.4 (95% CI, 153.3-155.5) hospitalizations per 10,000 persons ( Table 2 ). The rate increased slightly over time, from a low of 152.5 (95% CI, 150.0-155.4) in 1998 to a high of 166.7 (95% CI, 162.3-171.1) in 2005 ( ); a similar trend P ! .001 was seen for both male and female patients ( for both). P ! .001 Trends varied by age group, with the greatest increases in the hospitalization rate observed among those aged 40-59 years (Table 2 ). There was a difference in trends over time by race. Patients reporting Hispanic race/ethnicity experienced a slight increase in hospitalization rate from 1998 to 2006 (12.1%; ); there was a small decrease in the rate during this P ! .001 time period for black (Ϫ6.8%;
) and Asian/Pacific P p .004 Islander patients (Ϫ12.1%;
) and no significant change P p .046 for patients reporting white race (4.3%;
). P p .07 Hospitalization rates: demographic characteristics. Agespecific average annual ID hospitalization rates were highest among the youngest children (aged !5 years) and the oldest adults (agedу60 years) ( Table 2) . Female patients had a significantly higher ID hospitalization rate, compared with male patients, but the rate difference varied by age group. For the youngest age groups (those aged !1 and 1-4 years) and for those aged у40 years, male patients had a higher hospitalization rate; the hospitalization rate for female patients exceeded that for male patients in the middle age group (those aged 5-39 years). Consequently, the median age at the time of hospitalization among female patients was higher than that for male patients (59 years [interquartile range {IQR}, 31-78]) vs 53 years [IQR, 27-74] years). Racial/ethnic differences in ID hospitalization rates were observed, with highest rates among patients reporting black race/ethnicity, followed by those for patients reporting white and Hispanic race/ethnicity ( Table 2 ). The lowest ID hospitalization rates were seen among patients reporting Asian/Pacific Islander race; this was true for both male and female patients. Some regional variation was observed, with the highest hospitalization rates in the South and the lowest in the West. Part of this regional variation may be explained by different distributions of race/ethnic groups, but even when stratifying by race, regional differences remained. Among white and Hispanic patients, rates were higher in the Northeast and South; the highest rates were also seen in the South for black patients. However, rates among Asian/Pacific Islander patients were highest in the West.
Hospitalization outcomes, codiagnoses, and procedures. Among ID hospitalizations, 4.0% (SE, 0.02%) ended with inhospital death. Overall, the in-hospital fatality rate decreased slightly over the study period, from 4.1% (SE, 0.04%) in 1998-2000 to 3.8% (SE, 0.04%) in 2004-2006. The fatality rate was similar for men and women, with rates of 4.1% (SE, 0.03%) and 3.8% (SE, 0.02%), respectively. Fatality rates generally increased with age group; the lowest rates were among children aged 1-4 years (0.14%; SE, 0.01%), whereas adults aged у80 years had a fatality rate of 8.9% (SE, 0.04%).
The most commonly listed codiagnoses along with a primary ID diagnosis were: pneumonia, organism not specified (ICD-9-CM code 486; 26.5%; SE, 0.1%); essential hypertension, unspecified (ICD-9-CM code 401.9; 24.3%; SE, 0.1%); urinary tract infection, not otherwise specified (ICD-9-CM code 599.0; 15.9%; SE, 0.1%); volume depletion (ICD-9-CM code 276.5; 16.2%; SE, 0.1%); congestive heart failure, unspecified (ICD-9-CM code 428.0; 12.4%; SE, 0.1%); and diabetes mellitus type II, without mention of complication (ICD-9-CM code 250.00; 11.1%; SE, 0.1%); these were the most common codiagnoses among both male and female patients (Table 3 ). In the younger age groups (aged 0-19 years), infectious diseases (most commonly pneumonia, organism not specified [ICD-9-CM code 486; 17.5%; SE, 0.2%]) were the main diagnoses listed on hospitalization records, whereas for adults (aged 20-49 years) and older adults (aged у50 years), chronic diseases were more common. Of note, pneumonia remained a top diagnosis for hospitalizations for all age groups and was the most commonly listed diagnosis for those aged !50 years and the second most commonly listed for those aged у50 years. The most commonly reported nonroutine procedures listed for primary ID hospitalizations were venous catheterization not elsewhere classified (ICD-9-CM code 38.93; 7.7%; SE, 0.1%), transfusion of packed cells (ICD-9-CM code 99.04; 4.5%; SE, 0.1%), appendectomy (ICD-9-CM code 47.09; 3.8%; SE, 0.04%), and spinal tap (ICD-9-CM code 033.1; 3.1%; SE, 0.04%).
Hospital seasonality, duration of stay, and charges. Hospital admissions for IDs varied by season, with the largest proportion of hospitalizations occurring in the winter months (December-March, 34.3%), and the smallest proportion occurring in the summer months (June-September, 27.6%; Figure 1) . This variation may be largely attributable to the seasonal pattern of LRTI hospitalizations, which exhibited a strong peak during winter. ID hospitalizations were responsible for ∼4.5 million hospital days per year. The median duration of stay for a hospitalization was 3.27 (IQR, 1.73-6.00) days, and the average duration of stay was 5.56 (SE, 0.02) days. The median durations of stay for male and female patients were similar (3.26 [IQR, 1.68-6.09] days and 3.28 [IQR, 1.77-5.96] days, respectively). The median duration of stay increased with increasing age, from 1.77 (IQR, 1.00-2.91) days for hospitalizations among children aged 1-4 years to 4.46 (IQR, 2.63-7.37) days for hospitalizations among patients aged у80 years; this pattern was consistent by sex. Hospital charges for ID hospitalizations over the 9-year study period totaled 1$865 billion (SE, $9.6 billion); median charges for an ID hospitalization were $11,651 (IQR, $6457-$22,423). In accordance with findings regarding duration of stay, charges generally increased with age group, ranging from a median of $5526 (IQR, $3404-$9689) for children aged 1-4 years to $14,492 (IQR, $8010-$28,676) for those aged 60-69 years.
Infectious disease groups. Lower respiratory tract infections were the most common diagnosis listed for primary ID hospitalizations, accounting for 34.3% (SE, 0.10%) of the primary ID hospitalizations (Table 4 and Figure 2 ) and an average annual age-adjusted hospitalization rate of 529.4 (95% CI, 524.9-534.0) hospitalizations per 100,000 persons. The rate decreased from 1998 to 2006 (decrease, Ϫ14.7%;
). Female P ! .001 patients had a slightly higher hospitalization rate than male patients overall, although LRTI hospitalization rates were higher for male patients aged !20 and у60 years. Rates of hospitalization were highest among the children aged !5 years (hospitalization rate, 1376.4; 95% CI, 1325.0-1427.9) and among adults aged 70-79 years (hospitalization rate, 1838.5; 95% CI, 1813.8-1863.8) and у80 years (hospitalization rate, 4063.0; 95% CI, 4006.7-4119.3). Rates of LRTI hospitalizations did not change for children aged !5 years over the study period ( ) but did decrease significantly for the oldest adults P p .08 ( for those aged both 70-79 years and у80 years). P ! .001
Other common ID diagnoses among primary ID hospitalizations were kidney, urinary tract, and bladder infection; cellulitis; septicemia; and abdominal and rectal infection ( Figure  2) . Kidney, urinary tract, and bladder infection accounted for 10.3% (SE, 0.04%) of ID hospitalizations. Female patients were significantly more likely to be hospitalized with this diagnosis than male patients, and the highest rates were observed among adults aged у80 years (hospitalization rate, 1544.8; 95% CI, 1519.5-1570.0). Cellulitis accounted for a similar proportion of ID hospitalizations (10.1%; SE, 0.05%), with an overall ageadjusted rate of 156.2 hospitalizations per 100,000 persons (95% CI, 154.9-157.5) and a slight increase among male patients, compared with female patients. Septicemia and abdominal and rectal infection hospitalization rates were slightly higher among women, compared with that among men; however, the median age at admission was similar for both sexes in each case. Substantial differences by sex were noted in those hospitalized with a primary diagnosis of enteric infections, infections involving bone, HIV/AIDS, and tuberculosis. Female patients had an older median age at hospital admission, compared with male patients for many ID groups. For meningitis, upper respiratory tract infection, enteric infection, and osteomyelitis hospitalizations, the median age among female patients was у10 years greater than that among male patients.
The in-hospital fatality rate varied by ID group, with the highest fatality rates observed among those with first-listed diagnoses of septicemia (18.1%; SE, 0.10%), meningitis (8.1%; SE, 0.2%), and mycotic infection (8.0%; SE, 0.1%).
DISCUSSION
This study describes the burden and epidemiology of ID hospitalizations in the United States during 1998-2006. The annual hospitalization rate for IDs increased during the study period. The 2006 rate also showed an increase from an earlier reported ID hospitalization rate for 1994 ( hospitalizations per 1536 ‫ע‬ 70 100,000 persons) [2] . This rate increase appears to be attributable to an increase in hospitalizations among those aged у30 years, particularly among older adults. Although the overall ID hospitalization rate increased over time, differences were observed in specific ID groups. Furthermore, ID hospitalizations were associated with a significant economic burden. Hospital charges for IDs averaged at least $96 billion per year, and the hospital duration of stay averaged at least 4.5 million hospital days per year.
Differences by sex were noted for ID hospitalizations, with patterns of hospitalization varying by age group and by disease subgroup. In general, among female patients, older children and young adults experienced higher ID hospitalization rates, whereas among male patient, hospitalization rates were higher for younger children and those aged 140 years. Patients reporting black race/ethnicity experienced the highest ID hospitalization rates, compared with other race/ethnicity groups, but among black patients, the hospitalization rate decreased over the study period. This disparity may be attributable to socioeconomic factors and increased prevalence of certain risk factors for IDs (such as smoking) [30] . Although the present study was unable to examine ID hospitalization rates for American Indian/Alaska Native persons, earlier studies have demonstrated a higher rate of ID hospitalization among American Indian/Alaska Native persons using health care services funded by the Indian Health Service, especially in the Alaska and Southwest regions, compared with the rate for the general US population [13, 15] . Timely access to health care and suboptimal socioeconomic factors among American Indian/Alaska Native populations, which contain a disproportionate number of persons of lower socioeconomic status, may be one hypothesis to explain differences in ID hospitalization rates.
Lower respiratory tract infections continue to be the leading diagnosis for primary ID hospitalizations, although the proportion of hospitalizations with LRTIs decreased slightly over the study period. In 1994, LRTIs accounted for 37% of all ID hospitalizations [2] , and in this study they accounted for 34.3% (SE, 0.10%). Age-adjusted LRTI rates were higher among male patients, compared with female patients. Rates were also highest among young children and older adults. Although LRTI hospitalization rates did not change significantly for children aged !5 years over the study period, earlier studies described a rate increase for LRTI-associated hospitalizations among infants during the 1980s and 1990s in the United States [31, 32] . Among older persons, the hospitalization rate for pneumonia has been reported to have increased during 1988-2002 in the United States [33, 34] . Rates of ID hospitalization with septicemia increased over the study period, a trend that was noted for all age and sex groups. This trend was also noted in an earlier study, which used administrative data to examine septicemia hospitalizations among Medicare beneficiaries and demonstrated a doubling of rates between 1986 and 1997 [3] . Rates of hospitalization for HIV/AIDS; heart infection; cellulitis; infection due to internal prosthetic device, implant, and graft; postoperative infection; and infections related to pregnancy, childbirth, or puerperium all increased during the current study, compared with their respective rates for 1994, whereas the rates of hosDownloaded from https://academic.oup.com/cid/article-abstract/49/7/1025/314998 by guest on 28 January 2019 pitalization for kidney, urinary tract, and bladder infections and for upper respiratory tract infections decreased [2] .
There are some limitations to this study. Because no unique identifiers are available, the unit of analysis is a hospitalization, and multiple hospital admissions could not be identified. We relied on ICD-9-CM coding to identify ID hospitalizations, which may be incomplete and may differ by practice and by region. In addition, trends over time could be impacted by any changes in coding practices within facilities. However, there were no code conversions during the study period that impacted our ID group definitions. We identified ID hospitalizations with an ID listed as the primary diagnosis in an effort to limit potential misclassification of ID. However, because discharge information is used (admission codes are not available on the present Nationwide Inpatient Sample data), there is potential for the inclusion of nosocomial infections. Patient race/ethnicity was not available for ∼25% of the ID hospitalizations, which leads to an underestimation of ID hospitalization rates by race group and limits the ability to compare rates between races. Also, we did not examine ID hospitalizations among American Indian/Alaska Native patients, because the Nationwide Inpatient Sample data do not include hospitalizations in Indian Health Service-or tribally-operated health care facilities [29] .
Infectious disease hospitalization rates have increased over time and are associated with substantial morbidity, mortality, and economic consequences. Male patients were more likely to be hospitalized for infections involving bone, abdominal and rectal infections, HIV/AIDS, and tuberculosis. In comparison, female patients were at higher risk for hospitalization for enteric infection and for kidney, urinary tract, and bladder infection. Lower respiratory tract infections accounted for the largest proportion of ID hospitalizations for both sexes. Our findings reinforce the fact that IDs continue to be a source of considerable morbidity and mortality in the United States. Future efforts should focus on defining and improving preventive measures for IDs both in the community and in the health care setting, clarifying the role of antimicrobial-resistant organisms in the increase in ID hospitalizations in the United States, and improving early interventions in the case of treatable and preventable IDs.
